$FXE
Invesco CurrencyShares Euro Trust

2023 Q1 Form 10-K Financial Statement

#000156459023002366 Filed on February 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $910.5K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $284.8K $2.117M
YoY Change -46.02% -28.45%
Operating Profit
YoY Change
Interest Expense $1.008M
YoY Change -43.81%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings $625.7K -$1.786M
YoY Change -218.62% -39.63%
Net Earnings / Revenue 68.72%
Basic Earnings Per Share $0.22 -$0.62
Diluted Earnings Per Share $0.22 -$0.62
COMMON SHARES
Basic Shares Outstanding 2.950M 2.885M
Diluted Shares Outstanding 2.906M 2.885M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $270.6M $285.5M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $276.0M $285.7M
YoY Change 35.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $10.14M $118.7K
YoY Change -40.52%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity $276.0M $285.7M
YoY Change 35.0%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $625.7K -$1.786M
YoY Change -218.62% -39.63%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $405.1K -$2.043M
YoY Change -173.89% -32.03%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $396.5K $57.11K
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -20.71M 80.23M
YoY Change 6.35% -188.16%
NET CHANGE
Cash From Operating Activities 405.1K -2.043M
Cash From Investing Activities
Cash From Financing Activities -20.71M 80.23M
Net Change In Cash -14.91M 73.91M
YoY Change -42.12% -163.65%
FREE CASH FLOW
Cash From Operating Activities $405.1K -$2.043M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Interest Expense
InterestExpense
1794157
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Trading Symbol
TradingSymbol
FXE
CY2022 dei Security Exchange Name
SecurityExchangeName
NYSEArca
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
218025000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2950000
CY2022 dei Auditor Firm
AuditorFirmId
238
CY2022 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2022 dei Auditor Location
AuditorLocation
Chicago, Illinois
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
285555944
CY2021Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
211643424
CY2022Q4 us-gaap Assets
Assets
285725144
CY2022Q4 us-gaap Liabilities
Liabilities
118683
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
2900000
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
2900000
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
330793
CY2022 us-gaap Operating Expenses
OperatingExpenses
2116506
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1785713
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-2957966
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Registrant Name
EntityRegistrantName
Invesco CurrencyShares Euro Trust
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001328598
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
CY2022 fxe Share Purchase And Redemptions Settlement Period Creation And Redemption
SharePurchaseAndRedemptionsSettlementPeriodCreationAndRedemption
P2D
CY2021Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
CY2022 us-gaap Revenues
Revenues
CY2021 us-gaap Revenues
Revenues
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-32694
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3613421
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
3500 Lacey Road
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Downers Grove
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60515
CY2022 dei City Area Code
CityAreaCode
800
CY2022 dei Local Phone Number
LocalPhoneNumber
983-0903
CY2022 dei Security12b Title
Security12bTitle
Common Units of Beneficial Interest
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
169200
CY2021Q4 us-gaap Assets
Assets
211643424
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
7419
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
111264
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
75346
CY2021Q4 fxe Interest Payable On Currency Deposits Current
InterestPayableOnCurrencyDepositsCurrent
124198
CY2021Q4 us-gaap Liabilities
Liabilities
199544
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
2000000
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
2000000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
285606461
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
211443880
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
285725144
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
211643424
CY2022 us-gaap Sponsor Fees
SponsorFees
1108325
CY2021 us-gaap Sponsor Fees
SponsorFees
1163809
CY2022 us-gaap Interest Expense
InterestExpense
1008181
CY2021 us-gaap Operating Expenses
OperatingExpenses
2957966
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-2957966
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.13
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.13
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2884521
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2884521
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2626438
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2626438
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
57109
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1785713
CY2022 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
1842822
CY2021 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
2957966
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1785713
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-2957966
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
169200
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
35918
CY2021 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-33713
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-124198
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-14454
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2043193
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3006133
CY2022 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
57109
CY2022 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
703013411
CY2021 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
184370935
CY2022 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
622725114
CY2021 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
275381729
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
80231188
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-91010794
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4282894
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-22103870
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
73905101
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-116120797
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
211643424
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
327764221
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
285548525
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
211643424
CY2022 us-gaap Interest Paid Net
InterestPaidNet
1132379
CY2021 us-gaap Interest Paid Net
InterestPaidNet
1808611
CY2022 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2005-12-05
CY2022Q4 fxe Initial Incorporation Deposit With Bank Sponsor
InitialIncorporationDepositWithBankSponsor
100
CY2022 fxe Number Of Deposits Accounts In Which Trust Assets Primarily Consist Demand Deposit
NumberOfDepositsAccountsInWhichTrustAssetsPrimarilyConsistDemandDeposit
2
CY2022 fxe Stock Redeemable In Baskets Number Of Shares
StockRedeemableInBasketsNumberOfShares
50000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.54%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">B.</span></p></td> <td valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman Bold;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:10pt;font-family:Times New Roman;color:#000000;">Accounting Estimates</span></p></td></tr></table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the Trust monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are issued.</p>
CY2022 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.02
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
57109
CY2022Q4 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2023-01-10
CY2022Q4 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-01-04
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 fxe Minimum Period Required To Stay For Tax Liability
MinimumPeriodRequiredToStayForTaxLiability
P183D
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0060
CY2022 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
679568682
CY2022 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
596144853
CY2022 us-gaap Payments For Operating Activities
PaymentsForOperatingActivities
1970473
CY2022Q4 us-gaap Cash
Cash
267562001
CY2022Q4 us-gaap Cash
Cash
285555944
CY2021 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
154383268
CY2021 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
233628410
CY2021 us-gaap Payments For Operating Activities
PaymentsForOperatingActivities
2525944
CY2021Q4 us-gaap Cash
Cash
186108645
CY2021Q4 us-gaap Cash
Cash
211643424

Files In Submission

Name View Source Status
0001564590-23-002366-index-headers.html Edgar Link pending
0001564590-23-002366-index.html Edgar Link pending
0001564590-23-002366.txt Edgar Link pending
0001564590-23-002366-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fxe-10k_20221231.htm Edgar Link pending
fxe-20221231.xsd Edgar Link pending
fxe-ex231_10.htm Edgar Link pending
fxe-ex311_8.htm Edgar Link pending
fxe-ex312_7.htm Edgar Link pending
fxe-ex321_9.htm Edgar Link pending
fxe-ex322_6.htm Edgar Link pending
gqxpey5z0px4000001.jpg Edgar Link pending
gqxpey5z0px4000002.jpg Edgar Link pending
gqxpey5z0px4000003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fxe-20221231_def.xml Edgar Link unprocessable
fxe-20221231_lab.xml Edgar Link unprocessable
fxe-20221231_pre.xml Edgar Link unprocessable
fxe-10k_20221231_htm.xml Edgar Link completed
fxe-20221231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable